公开(公告)号：US09738626B2

公开(公告)日：2017-08-22

申请号：US14970930

申请日：2015-12-16

Applicant: Pfizer Inc.

Inventor： Kevin Bahnck ,  Daniel Canterbury ,  David James Edmonds ,  Kentaro Futatsugi ,  Esther Cheng Yin Lee ,  Elnaz Menhaji-Klotz ,  Jana Polivkova ,  Robert Vernon Stanton

IPC: C07D401/14

CPC classification number: C07D401/14

Abstract: Provided herein are antagonists of prostaglandin EP3 receptor, processes to make said antagonists, and methods comprising administering said antagonists to a mammal in need thereof.

公开(公告)号：US20160176851A1

公开(公告)日：2016-06-23

申请号：US14970930

申请日：2015-12-16

Applicant: Pfizer Inc.

Inventor： Kevin Bahnck ,  Daniel Canterbury ,  David James Edmonds ,  Kentaro Futatsugi ,  Esther Cheng Yin Lee ,  Elnaz Menhaji-Klotz ,  Jana Polivkova ,  Robert Vernon Stanton

IPC: C07D401/14

CPC classification number: C07D401/14

Abstract: Provided herein are antagonists of prostaglandin EP3 receptor, processes to make said antagonists, and methods comprising administering said antagonists to a mammal in need thereof.